NIMENRIX (Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine) Health Professional Information

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

SUMMARY PRODUCT INFORMATION

 

1conjugated to tetanus toxoid carrier protein 44 micrograms

Route of Administration

Dosage Form / Strength

Clinically Relevant Nonmedicinal Ingredients

Intramuscular Injection

Powder and diluent for solution for injection

Neisseria meningitidis serogroup A polysaccharide1
5 micrograms

Neisseria meningitidis serogroup C polysaccharide1
5 micrograms

Neisseria meningitidis serogroup W-135 polysaccharide1
5 micrograms

Neisseria meningitidis serogroup Y polysaccharide1
5 micrograms

Sucrose

Trometamol

Sodium chloride

For a complete listing see Dosage Forms, Composition and Packaging section.